Study at a glance
How were vitamin D-related compounds tested for eye and kidney cell damage?
Researchers tested vitamin D-related compounds in laboratory cells and mice. One study exposed retinal cells from the eye to hydrogen peroxide and tested calcitriol, the active vitamin D hormone. Another tested paricalcitol, a drug that activates the vitamin D receptor, in kidney cells exposed to high glucose and in mice with diabetes.
Did the tested compounds reduce signs of eye and kidney damage?
Several measurements showed less damage from reactive chemicals in the retinal-cell model, although not every protective response increased clearly. The kidney experiments showed improvements in damage linked with reactive chemicals and iron. Treated mice also had better results on urine protein loss and tissue injury. These findings concern the tested models, not human treatment outcomes.
Did tests explain how the cell protection happened?
In kidney cells, reducing Nrf2, a molecule that helps control protective responses, removed or weakened the protection. This supports its importance in those cells. The retinal study did not test whether Nrf2 or another proposed signalling substance was required. Some earlier steps proposed for the proposed process in the kidney were also not directly established. Changes occurring together are weaker evidence than interrupting a process and observing the result.
Do the findings establish protection for human eyes or kidneys?
The cell experiments do not prove that the same mechanism explains every result in mice. Changes in mouse weight and glucose could also affect kidney injury. Better appearance of structures inside cells does not establish complete recovery of their function or reversal of cellular ageing. Calcitriol and paricalcitol are not ordinary vitamin D3 supplements. Human benefits, long-term protection and a supplement dose remain unestablished.
Read the full article below ↓Vitamin D-related compounds improved redox and injury measurements in experimental retinal and kidney models. The studies differed in how directly they tested the mechanism: the retinal study showed coordinated changes, while the kidney study used Nrf2 knockdown to test dependence. Neither establishes that ordinary vitamin D supplementation prevents retinal or kidney disease in people. Read the companion Vitamin D, Cellular Redox Balance and Tissue Injury: Full Evidence Review.
Retinal cells under oxidative challenge
Tohari and colleagues exposed ARPE-19 retinal pigment epithelial cells to hydrogen peroxide and studied calcitriol. Several measurements indicated less oxidative injury and altered antioxidant responses. NRF2 and IL-33-related expression also changed.
However, the researchers did not remove or block NRF2 or IL-33 to show that either was necessary for the protection. GPX1 did not show a clear increase in the reported experiment. The result therefore supports a protective response in the cell model, not activation of every antioxidant mechanism.
This is evidence relevant to Vitamin D and Oxidative Stress. It is not a clinical trial, and the laboratory concentration cannot be converted into a personal supplement dose.
Kidney cells and diabetic mice
Wang and colleagues studied paricalcitol, a vitamin D receptor agonist, in high-glucose-exposed HK-2 cells and diabetic mice. Redox, iron-handling and ferroptosis-related measurements improved in the reported experiments. Treated mice also showed improvements in albuminuria and tissue-injury measurements.
Reducing Nrf2 with small interfering RNA removed or attenuated the protective cellular response. This provides stronger evidence of pathway dependence than observing increased Nrf2 alone. The dependency was tested in cells, however, and should not be extended into proof that Nrf2 explained every animal outcome.
The proposed upstream VDR: Nrf2 binding step was less directly established. Predicted binding and colocalisation are not equivalent to direct promoter-binding evidence. Paricalcitol also affected weight and glucose in the mice, complicating attribution of kidney protection solely to a direct renal mechanism. A separate study by He and colleagues added VDR loss/gain experiments and direct GPX4 promoter-binding tests. It supports a complementary renal mechanism, without proving nutritional vitamin D efficacy or Wang’s proposed VDR: Nrf2 binding step.
What the measurements do not mean
Improved mitochondrial appearance is relevant to Vitamin D and Mitochondrial Function, but it does not establish complete restoration of mitochondrial function. Reduced oxidative injury likewise does not prove reversal of cellular senescence, the distinct process discussed in Vitamin D and Cellular Senescence. Those outcomes require their own measurements.
Calcitriol and paricalcitol are different experimental agents. Their effects in cells and mice do not establish a nutritional vitamin D3 treatment effect. Vitamin D Status vs Vitamin D Effect helps distinguish a circulating status measurement from the biological response tested in a particular tissue model.
The studies are related to Vitamin D and Inflammatory Signalling, but they do not prove that every protective redox effect was caused by inflammatory suppression. Vitamin D Signalling Pathways helps explain the receptor-pathway question, while Why Vitamin D Results Differ provides context for comparing different agents, tissues and exposure conditions without treating them as equivalent clinical tests.
Conclusion
The evidence supports experimental redox protection with different levels of mechanistic certainty. The retinal study is mainly associative at the pathway level; the kidney study adds a cellular Nrf2-dependency test and animal tissue outcomes. Human efficacy, long-term benefit and a supplementation regimen remain unestablished.
This page is an original Vitamin D3 For Life explanation and critical appraisal of the research cited below.
Primary source and publication details
Related reading
Vitamin D Attenuates Oxidative Damage and Inflammation in Retinal Pigment Epithelial Cells
In the current study, we investigated the impact of VITD on H2O2-induced oxidative stress and inflammation in human RPE cells.
Original paper ↗Read more →Active Vitamin D and Vitamin D Receptor Help Prevent High Glucose Induced Oxidative Stress of Renal Tubular Cells via AKT/UCP2 Signaling Pathway
JC-1 was evaluated by flow cytometry.
Original paper ↗Read more →Protective effect of calcitriol on rhabdomyolysis-induced acute kidney injury in rats
This study evaluated the effect of calcitriol administration in AKI induced by rhabdomyolysis and its relationship with oxidative damage and inflammatory process.
Original paper ↗Read more →DKS26 Alleviates Ischemia-Reperfusion Injury-Induced Acute Kidney Injury by Stabilizing Vitamin D Receptors to Inhibit the Inflammatory Pathway of NF-κB P65
This study aimed to investigate the therapeutic effects of DKS26 on AKI and its underlying molecular mechanisms.
Original paper ↗Read more →Vitamin D receptor attenuate ischemia-reperfusion kidney injury via inhibiting ATF4
Activating transcription factor 4 (ATF4) is one of the key effectors of endoplasmic reticulum stress (ERS), ATF4/CHOP pathway-mediated ERS plays an important role in the progression of acute kidney disease (AKI).
Original paper ↗Read more →Association of Oxidative Stress Markers with Cardio-Kidney-Metabolic Parameters and Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
We aimed to investigate the association between oxidative stress (OS), inflammation, and kidney function and the predictive ability of OS for mortality and cardiovascular disease in 143 patients with type 2 diabetes (T2DM) and various degrees of kidney function.
Original paper ↗Read more →The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus
This study aimed to evaluate the state of inflammation and oxidative stress (OS) on the progression of CKD in the early stages in patients with and without type 2 diabetes mellitus (T2DM).
Original paper ↗Read more →Vitamin D deficiency is not associated with increased oxidative stress in chronic kidney disease pre-dialysis patients
The progressive decline in 25-hydroxyvitamin D [25(OH)D] in chronic kidney disease (CKD) limits the kidney ability of synthesizing the vitamin.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation
In this study, the biological effect and epigenetic regulation of calcitriol on kidney cancer cells were investigated.
Original paper ↗Read more →Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
Therefore, we conducted a study to determine whether paricalcitol, compared to calcitriol, improves anemia in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes
We aimed to examine associations among serum 25-hydroxyvitamin D (25OHD) levels, 1,25-dihyroxyvitamin D (1,25OHD) levels, vitamin D receptor (VDR) polymorphisms, and renal function based on estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes.
Original paper ↗Read more →Low-dose oral cholecalciferol is associated with higher numbers of Helios+ and total Tregs than oral calcitriol in renal allograft recipients: an observational study
We evaluated whether there was a difference in the absolute numbers of Helios+, Helios−, CTLA-4+, IFNg+, and total Tregs among the patient groups.
Original paper ↗Read more →MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma
To investigate the expression of miR-125b and vitamin D receptor (VDR) in renal cell carcinoma (RCC) and assess the biological function of miR-125b in RCC.
Original paper ↗Read more →Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease
The objective of this study was to explore whether VDRA administration during the predialysis period is associated with a reduced prevalence of uremic nausea just prior to beginning dialysis.
Original paper ↗Read more →The Altered Proteomic Landscape in Renal Tubular Epithelial Cells under High Oxalate Stimulation
Our study aimed to apply a proteomic approach to investigate the molecular mechanisms underlying the effects of oxalate on rat renal tubular epithelial cells.
Original paper ↗Read more →Vitamin D Receptor Gene Polymorphism and Left Ventricular Hypertrophy in Chronic Kidney Disease
FokI and BsmI polymorphisms of vitamin D receptor (VDR) gene are regarded as reliable markers of disturbed vitamin D signaling pathway.
Original paper ↗Read more →Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches
Here, we aimed to assess the correlation between the different alleles of VDR gene polymorphisms and renal cell cancer and breast cancer risks separately through a systematic review of the present literature.
Original paper ↗Read more →Vitamin D receptor polymorphisms and bone health after kidney transplantation
We investigated the relationship between the polymorphisms of the vitamin D receptor ( VDR ) gene and bone diseases occurring after kidney transplantation.
Original paper ↗Read more →Vitamin D and Oxidative Stress
Explore how vitamin D fits into oxidative stress regulation, antioxidant balance, mitochondrial activity, and cellular signalling without reductionist claims.
Read more →Original sources
Vitamin D Attenuates Oxidative Damage and Inflammation in Retinal Pigment Epithelial Cells
In the current study, we investigated the impact of VITD on H2O2-induced oxidative stress and inflammation in human RPE cells.
Publication details
Vitamin D Attenuates Oxidative Damage and Inflammation in Retinal Pigment Epithelial Cells. Ali Mohammad Tohari, Reem Hasaballah Alhasani, Lincoln Biswas, Sarita Rani Patnaik, James Reilly, Zhihong Zeng, Xinhua Shu. Antioxidants; 2019; 8; 9; 341. DOI: 10.3390/antiox8090341. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.
VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf 2/HO‐1 Signaling Pathway in Diabetic Nephropathy
VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf 2/HO‐1 Signaling Pathway in Diabetic Nephropathy.
Publication details
VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf 2/HO‐1 Signaling Pathway in Diabetic Nephropathy. Hui Wang, Xiaoyue Yu, Dongwei Liu, Yingjin Qiao, Jinling Huo, Shaokang Pan, Lijuan Zhou, Rui Wang, Qi Feng, Zhangsuo Liu. Advanced Science; 2024; 11; 10; 2305563. DOI: 10.1002/advs.202305563. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.
PRPF19 mediates the proteasomal degradation of VDR to exacerbate ferroptosis in diabetic nephropathy
PRPF19 mediates the proteasomal degradation of VDR to exacerbate ferroptosis in diabetic nephropathy.
Publication details
PRPF19 mediates the proteasomal degradation of VDR to exacerbate ferroptosis in diabetic nephropathy. Qiongyao He, Wu He, Yanlin Ren, Wenbin Wu, Hui Dong, Gang Yuan, Huihui Ren, Xinwei Wang, Fuer Lu, Dingkun Wang. Cell Communication and Signaling : CCS; 2025; 23; 242. DOI: 10.1186/s12964-025-02253-5. CC BY-NC-ND; linked here for brief factual context only.